Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized study of Taxotere alone versus Taxotere plus curcumin in HER2-negative advanced breast cancer
2008-003930-19Phase 2Terminated
- Sponsor
- Centre Jean Perrin
- Start
- Mar 2009
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in breast cancer comparing Taxotere monotherapy with Taxotere plus curcumin (2 arms). Primary endpoints: Objective response rate and Clinical benefit rate. Started Mar 2009; status: terminated.
02
Drugs
docetaxelcurcumin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-003930-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003930-19.